Sign In
Buy LLY
$1,131.42
+6.04 (+0.537%)
At Close: Jun 05, 2026
Eli Lilly (LLY) Stock Price Prediction and Forecast 2025-2030
06:30am, Thursday, 12'th Dec 2024
Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 504.34% and currently trading at $799.00. The company has been around since 1876 and the
Eli Lilly (LLY) Stock Slides as Market Rises: Facts to Know Before You Trade
06:52pm, Wednesday, 11'th Dec 2024
Eli Lilly (LLY) concluded the recent trading session at $796.03, signifying a -0.44% move from its prior day's close.
Telehealth firm Ro to provide single-dose vials of Lilly's Zepbound to obesity patients
08:23am, Wednesday, 11'th Dec 2024
Telehealth company Ro said on Wednesday it will provide access to single-dose vials of Eli Lilly's weight-loss drug Zepbound to patients with obesity.
As monotherapy, imlunestrant significantly reduced the risk of progression or death by 38% compared to standard endocrine therapy (ET) in patients with ESR1 mutations As combination therapy, imlunest
Ro to offer lower-price vials of weight loss drug Zepbound by teaming up with Eli Lilly
08:01am, Wednesday, 11'th Dec 2024
Direct-to-consumer health-care startup Ro said its platform will now offer more affordable single-dose vials of the weight loss drug Zepbound through a new partnership with Eli Lilly. Ro will offer a
Lilly CEO says tax and regulation reform, drug affordability are focuses under Trump
03:49pm, Tuesday, 10'th Dec 2024
Eli Lilly CEO David Ricks on Tuesday said at the Economic Club of Washington that tax and regulation reform and drug affordability were some policy focuses for the company in a second Trump administra
Lilly Will Test Obesity Drugs on Addiction, CEO Says
03:22pm, Tuesday, 10'th Dec 2024
Eli Lilly & Co. will begin studies to see if its blockbuster weight-loss medicines can also be used to treat addictive behaviors like alcohol abuse, smoking and drug addiction, Chief Executive Office
Eli Lilly's $15 Billion Buyback Faces Stiff Resistance On The Charts
01:59pm, Tuesday, 10'th Dec 2024
Eli Lilly and Co LLY is making headlines with its $15 billion share buyback plan and a 15% dividend boost.
2 Stocks Top Global Fund Managers Have Been Buying
11:50am, Tuesday, 10'th Dec 2024
Some of the industry's best stock-pickers are buying these names—but should you? 00:00 Introduction 00:35 Eli Lilly LLY 01:20 Broadcom AVGO I'm Susan Dziubinski with Morningstar.
Jim Cramer reveals the most overlooked stock for 2025
10:51am, Tuesday, 10'th Dec 2024
Late on December 9, the former hedge fund manager and energetic host of Mad Money, Jim Cramer, took to X to share his two cents on which sectors in the stock market are overrepresented and which are b
Eli Lilly and Company (LLY) is Attracting Investor Attention: Here is What You Should Know
10:05am, Tuesday, 10'th Dec 2024
Lilly (LLY) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Lilly Announces New $15B Stock Buyback Plan, Ups Dividend by 15%
08:40am, Tuesday, 10'th Dec 2024
LLY's board approves a new $15B stock buyback plan and announces a 15% increase in its quarterly dividend.
Results from BRUIN CLL-321 show Lilly's pirtobrutinib reduced the risk of disease progression or death by 46% compared to idelalisib plus rituximab or bendamustine plus rituximab Pirtobrutinib prolong
Lilly announces new $15 billion share repurchase program and seventh consecutive 15% dividend increase
04:17pm, Monday, 09'th Dec 2024
INDIANAPOLIS , Dec. 9, 2024 /PRNewswire/ -- Today, the board of directors of Eli Lilly and Company (NYSE: LLY) approved a new $15 billion share repurchase program. The company's prior $5 billion share
CORE Kidney, Boehringer Ingelheim and Lilly Are Turning Up the Volume on Kidney Health at the 2025 Tournament of Roses® Parade
09:00am, Monday, 09'th Dec 2024
Pro Football Hall of Famer Brian Dawkins joins the team to motivate those at risk for kidney disease to prioritize complete testing LOS ANGELES , Dec. 9, 2024 /PRNewswire/ -- CORE Kidney, a patient
